Charles Faith L. — SEC Form 4 filings
SEC reporting owner CIK 1853985. 14 Form 4 filings on record with FilingPulse; latest filed 2026-05-20.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-04-10 to 2026-05-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 14,650 shares, $58,766 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 10,738 shares, $62,879 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 10,738 shares @ $5.86 ($62,879) in ABEONA THERAPEUTICS INC., filed 2025-07-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | Director | 6 | 1 leg · 7,550 sh · $24,764 | 1 leg · 10,738 sh · $62,879 | 4 |
| CNS Pharmaceuticals, Inc. (CNSP) | Director | 3 | 1 leg · 7,100 sh · $34,002 | — | 3 |
| CONDUIT PHARMACEUTICALS INC. (CDT) | Director | 4 | — | — | 5 |
| AVENUE THERAPEUTICS, INC. (ATXI) | Director | 1 | — | — | 1 |
Form 4 filings — Charles Faith L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-20 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase (P): 7,100 @ $4.79 | EDGAR |
| 2026-01-27 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 37,313 @ $0 | EDGAR |
| 2025-11-19 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 1,517 (derivative) @ $0 | EDGAR |
| 2025-07-10 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Sale (S): 10,738 @ $5.86 | EDGAR |
| 2025-04-17 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 115,194 @ $0.87 | EDGAR |
| 2025-04-01 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 46,629 @ $0.89 | EDGAR |
| 2025-02-03 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 36,101 @ $0 | EDGAR |
| 2024-12-20 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 420,000 (derivative) @ $0.07 | EDGAR |
| 2024-11-20 | 4 | CONDUIT PHARMACEUTICALS INC. (CDT) | Grant/award (A): 75,000 · Grant/award (A): 266,594 @ $0.09 | EDGAR |
| 2024-09-25 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 11,797 @ $0 | EDGAR |
| 2024-07-09 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Grant/award (A): 23,611 @ $0 | EDGAR |
| 2024-04-29 | 4 | ABEONA THERAPEUTICS INC. (ABEO) | Purchase (P): 7,550 @ $3.28 | EDGAR |
| 2024-04-10 | 4 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/award (A): 17,500 (derivative) · Grant/award (A): 17,500 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1853985 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →